Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Inhibitors

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

Results 1 - 10 of 39 > >>
download as CSV
download all results as CSV
EC Number Inhibitors Commentary Structure
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.138(4aR,6aS,12aS,12bR)-10-hydroxy-4,4,6a,12b-tetramethyl-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H-benzo(a)xanthene-8,11-dione KD, enantiomer of K1, strongly inhibits CerK activity Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.138(4aS,6aR,12aR,12bS)-10-hydroxy-4,4,6a,12b-tetramethyl-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H-benzo(a)xanthene-8,11-dione K1, non-competitive, suppresses the activation of mast cells, strongly inhibits CerK activity Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.138(4aS,6aR,12aR,12bS)-10-hydroxy-4,4,6a,12b-tetramethyl-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H-benzo(a)xanthene-8,11-dione ceramide kinase inhibitor K1, reduces the differences in degranulation observed between the bone marrow-derived mast cells from CERK-/- and wild-type mice in a dose-dependent manner Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.1381alpha,25-dihydroxyvitamin D3 enzyme activity decreases by approximately 40% in the presence of the hormone Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.1382,5-dihydroxy-3-(((1R,4aR,8aR)-5,5,8a-trimethyl-2-methylidenedecahydronaphthalen-1-yl)methyl)cyclohexa-2,5-diene-1,4-dione KB, enantiomer of K1, strongly inhibits CerK activity Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.1382,5-dihydroxy-3-(((1S,2S,4aS,8aR)-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl)methyl)cyclohexa-2,5-diene-1,4-dione KC, F12509A with an additional hydrogen at the double bond in methylene position, weak inhibition Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.1382,5-dihydroxy-3-(((1S,4aS,8aS)-5,5,8a-trimethyl-2-methylidenedecahydronaphthalen-1-yl)methyl)cyclohexa-2,5-diene-1,4-dione F12509A, inhibitor of sphingosine kinase 1, weak inhibition Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.1382,5-dihydroxy-3-[[(4aS,8aS)-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]methyl]cyclohexa-2,5-diene-1,4-dione K1, novel F-12509A olefin isomer, inhibitor decreases ceramide 1-phosphate levels without changing other lipids such as ceramide and sphingomyelin Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.1383,3-cholamidopropyl-dimethylammonio-1-propanesulfonate almost complete inhibition at high concentrations Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.1383-(cyclohexylmethyl)-2,5-dihydroxycyclohexa-2,5-diene-1,4-dione K2, cyclohexane derivative with a benzoquinone, weak inhibition Go to the Ligand Summary Page
Results 1 - 10 of 39 > >>
download as CSV
download all results as CSV